<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36067613</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-1582</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>NeuroImage. Clinical</Title><ISOAbbreviation>Neuroimage Clin</ISOAbbreviation></Journal><ArticleTitle>Cortical and subcortical grey matter atrophy in Amyotrophic Lateral Sclerosis correlates with measures of disease accumulation independent of disease aggressiveness.</ArticleTitle><Pagination><StartPage>103162</StartPage><MedlinePgn>103162</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">103162</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nicl.2022.103162</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-1582(22)00227-3</ELocationID><Abstract><AbstractText>There is a growing demand for reliable biomarkers to monitor disease progression in Amyotrophic Lateral Sclerosis (ALS) that also take the heterogeneity of ALS into account. In this study, we explored the association between Magnetic Resonance Imaging (MRI)-derived measures of cortical thickness (CT) and subcortical grey matter (GM) volume with D50 model parameters. T1-weighted MRI images of 72 Healthy Controls (HC) and 100 patients with ALS were analyzed using Surface-based Morphometry for cortical structures and Voxel-based Morphometry for subcortical Region-Of-Interest analyses using the Computational Anatomy Toolbox (CAT12). In Inter-group contrasts, these parameters were compared between patients and HC. Further, the D50 model was used to conduct subgroup-analyses, dividing patients by a) Phase of disease covered at the time of MRI-scan and b) individual overall disease aggressiveness. Finally, correlations between GM and D50 model-derived parameters were examined. Inter-group analyses revealed ALS-related cortical thinning compared to HC located mainly in frontotemporal regions and a decrease in GM volume in the left hippocampus and amygdala. A comparison of patients in different phases showed further cortical and subcortical GM atrophy along with disease progression. Correspondingly, regression analyses identified negative correlations between cortical thickness and individual disease covered. However, there were no differences in CT and subcortical GM between patients with low and high disease aggressiveness. By application of the D50 model, we identified correlations between cortical and subcortical GM atrophy and ALS-related functional disability, but not with disease aggressiveness. This qualifies CT and subcortical GM volume as biomarkers representing individual disease covered to monitor therapeutic interventions in ALS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dieckmann</LastName><ForeName>Nora</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roediger</LastName><ForeName>Annekathrin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prell</LastName><ForeName>Tino</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, University Hospital Halle, Halle, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuster</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Precision Neurology, University of L&#xfc;beck, Luebeck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herdick</LastName><ForeName>Meret</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Precision Neurology, University of L&#xfc;beck, Luebeck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayer</LastName><ForeName>Thomas E</ForeName><Initials>TE</Initials><AffiliationInfo><Affiliation>Department of Neuroradiology, University Hospital Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witte</LastName><ForeName>Otto W</ForeName><Initials>OW</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinbach</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospital Jena, Jena, Germany. Electronic address: Robert.Steinbach@med.uni-jena.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grosskreutz</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Precision Neurology, University of L&#xfc;beck, Luebeck, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Neuroimage Clin</MedlineTA><NlmUniqueID>101597070</NlmUniqueID><ISSNLinking>2213-1582</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066128" MajorTopicYN="N">Gray Matter</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic Lateral Sclerosis</Keyword><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">CAT12</Keyword><Keyword MajorTopicYN="N">Cortical Thickness</Keyword><Keyword MajorTopicYN="N">D50-model</Keyword><Keyword MajorTopicYN="N">MRI</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>6</Day><Hour>18</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36067613</ArticleId><ArticleId IdType="pmc">PMC9460837</ArticleId><ArticleId IdType="doi">10.1016/j.nicl.2022.103162</ArticleId><ArticleId IdType="pii">S2213-1582(22)00227-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abrahams S., Newton J., Niven E., Foley J., Bak T.H. Screening for cognition and behaviour changes in ALS. Amyotroph. Lateral Scler. Frontotemporal. Degener. 2014;15(1-2):9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">23781974</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F., Pagani E., Rocca M.A., Caputo D., Perini M., Salvi F., Prelle A., Filippi M. Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum. Brain Mapp. 2007;28(12):1430&#x2013;1438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6871473</ArticleId><ArticleId IdType="pubmed">17370339</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F., Valsasina P., Riva N., Copetti M., Messina M.J., Prelle A., Comi G., Filippi M., Le W. The cortical signature of amyotrophic lateral sclerosis. PLoS ONE. 2012;7(8):e42816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3412820</ArticleId><ArticleId IdType="pubmed">22880116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed R.M., Bocchetta M., Todd E.G., Tse N.Y., Devenney E.M., Tu S., Caga J., Hodges J.R., Halliday G.M., Irish M., Kiernan M.C., Piguet O., Rohrer J.D. Tackling clinical heterogeneity across the amyotrophic lateral sclerosis-frontotemporal dementia spectrum using a transdiagnostic approach. Brain Commun. 2021;3:fcab257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8599039</ArticleId><ArticleId IdType="pubmed">34805999</ArticleId></ArticleIdList></Reference><Reference><Citation>Anticevic A., Dierker D.L., Gillespie S.K., Repovs G., Csernansky J.G., Van Essen D.C., Barch D.M. Comparing surface-based and volume-based analyses of functional neuroimaging data in patients with schizophrenia. Neuroimage. 2008;41(3):835&#x2013;848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2527864</ArticleId><ArticleId IdType="pubmed">18434199</ArticleId></ArticleIdList></Reference><Reference><Citation>Appollonio I., Leone M., Isella V., Piamarta F., Consoli T., Villa M.L., Forapani E., Russo A., Nichelli P. The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol. Sci. 2005;26(2):108&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">15995827</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashburner J., Friston K.J. Voxel-based morphometry&#x2013;the methods. Neuroimage. 2000;11(6):805&#x2013;821.</Citation><ArticleIdList><ArticleId IdType="pubmed">10860804</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakker L.A., Schr&#xf6;der C.D., Tan H.H.G., Vugts S.M.A.G., van Eijk R.P.A., van Es M.A., Visser-Meily J.M.A., van den Berg L.H. Development and assessment of the inter-rater and intra-rater reproducibility of a self-administration version of the ALSFRS-R. J. Neurol. Neurosurg. Psychiatry. 2020;91(1):75&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">31558653</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Hardiman O. Longitudinal structural changes in ALS: a three time-point imaging study of white and gray matter degeneration. Amyotroph. Lateral Scler. Frontotemporal. Degener. 2018;19(3-4):232&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pubmed">29214883</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Elamin M., Byrne S., McLaughlin R.L., Kenna K., Vajda A., Pender N., Bradley D.G., Hardiman O. Basal ganglia involvement in amyotrophic lateral sclerosis. Neurology. 2013;81(24):2107&#x2013;2115.</Citation><ArticleIdList><ArticleId IdType="pubmed">24212388</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Omer T., Finegan E., Chipika R.H., Iyer P.M., Doherty M.A., Vajda A., Pender N., McLaughlin R.L., Hutchinson S., Hardiman O. Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: a multimodal neuroimaging study. Brain Imaging Behav. 2018;12(6):1696&#x2013;1707.</Citation><ArticleIdList><ArticleId IdType="pubmed">29423814</ArticleId></ArticleIdList></Reference><Reference><Citation>Benbrika S., Doidy F., Carluer L., Mondou A., Pelerin A., Eustache F., Viader F., Desgranges B. Longitudinal Study of Cognitive and Emotional Alterations in Amyotrophic Lateral Sclerosis: Clinical and Imaging Data. Front. Neurol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8296637</ArticleId><ArticleId IdType="pubmed">34305771</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000;1(5):293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardenas-Blanco A., Machts J., Acosta-Cabronero J., Kaufmann J., Abdulla S., Kollewe K., Petri S., Schreiber S., Heinze H.J., Dengler R., Vielhaber S., Nestor P.J. Structural and diffusion imaging versus clinical assessment to monitor amyotrophic lateral sclerosis. Neuroimage Clin. 2016;11:408&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4827722</ArticleId><ArticleId IdType="pubmed">27104135</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z.Y., Liu M.Q., Ma L. Cortical thinning pattern of bulbar- and spinal-onset amyotrophic lateral sclerosis: a surface-based morphometry study. Chin. Med. Sci. J. 2018;33:100&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">29976279</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu R., Hurwitz S., Tauhid S., Bakshi R. Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability. BMC Neurol. 2017;17:172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5584325</ArticleId><ArticleId IdType="pubmed">28874119</ArticleId></ArticleIdList></Reference><Reference><Citation>Creavin, S.T., Wisniewski, S., Noel-Storr, A.H., Trevelyan, C.M., Hampton, T., Rayment, D., Thom, V.M., Nash, K.J., Elhamoui, H., Milligan, R., Patel, A.S., Tsivos, D.V., Wing, T., Phillips, E., Kellman, S.M., Shackleton, H.L., Singleton, G.F., Neale, B.E., Watton, M.E., Cullum, S., 2016. Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst Rev, CD011145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8812342</ArticleId><ArticleId IdType="pubmed">26760674</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahnke R., Yotter R.A., Gaser C. Cortical thickness and central surface estimation. Neuroimage. 2013;65:336&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pubmed">23041529</ArticleId></ArticleIdList></Reference><Reference><Citation>d'Ambrosio A., Gallo A., Trojsi F., Corbo D., Esposito F., Cirillo M., Monsurro M.R., Tedeschi G. Frontotemporal cortical thinning in amyotrophic lateral sclerosis. AJNR Am. J. Neuroradiol. 2014;35(2):304&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7965753</ArticleId><ArticleId IdType="pubmed">24113470</ArticleId></ArticleIdList></Reference><Reference><Citation>de Albuquerque M., Branco L.M., Rezende T.J., de Andrade H.M., Nucci A., Franca M.C., Jr. Longitudinal evaluation of cerebral and spinal cord damage in Amyotrophic Lateral Sclerosis. Neuroimage Clin. 2017;14:269&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5294732</ArticleId><ArticleId IdType="pubmed">28203530</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai R., Liebenthal E., Possing E.T., Waldron E., Binder J.R. Volumetric vs. surface-based alignment for localization of auditory cortex activation. Neuroimage. 2005;26(4):1019&#x2013;1029.</Citation><ArticleIdList><ArticleId IdType="pubmed">15893476</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreger M., Steinbach R., Gaur N., Metzner K., Stubendorff B., Witte O.W., Grosskreutz J. Cerebrospinal fluid neurofilament light chain (NfL) predicts disease aggressiveness in amyotrophic lateral sclerosis: An application of the D50 disease progression model. Front. Neurosci. 2021;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8056017</ArticleId><ArticleId IdType="pubmed">33889072</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois B., Slachevsky A., Litvan I., Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55(11):1621&#x2013;1626.</Citation><ArticleIdList><ArticleId IdType="pubmed">11113214</ArticleId></ArticleIdList></Reference><Reference><Citation>Entis J.J., Doerga P., Barrett L.F., Dickerson B.C. A reliable protocol for the manual segmentation of the human amygdala and its subregions using ultra-high resolution MRI. Neuroimage. 2012;60(2):1226&#x2013;1235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3665767</ArticleId><ArticleId IdType="pubmed">22245260</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E., Hi Shing S.L., Chipika R.H., McKenna M.C., Doherty M.A., Hengeveld J.C., Vajda A., Donaghy C., McLaughlin R.L., Hutchinson S., Hardiman O., Bede P. Thalamic, hippocampal and basal ganglia pathology in primary lateral sclerosis and amyotrophic lateral sclerosis: Evidence from quantitative imaging data. Data Brief. 2020;29:105115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7005372</ArticleId><ArticleId IdType="pubmed">32055654</ArticleId></ArticleIdList></Reference><Reference><Citation>Floeter M.K., Bageac D., Danielian L.E., Braun L.E., Traynor B.J., Kwan J.Y. Longitudinal imaging in C9orf72 mutation carriers: Relationship to phenotype. Neuroimage Clin. 2016;12:1035&#x2013;1043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5153604</ArticleId><ArticleId IdType="pubmed">27995069</ArticleId></ArticleIdList></Reference><Reference><Citation>Frangou S., Modabbernia A., Williams S.C.R., Papachristou E., Doucet G.E., Agartz I., Aghajani M., Akudjedu T.N., Albajes-Eizagirre A., Alnaes D., Alpert K.I., Andersson M., Andreasen N.C., Andreassen O.A., Asherson P., Banaschewski T., Bargallo N., Baumeister S., Baur-Streubel R., Bertolino A., Bonvino A., Boomsma D.I., Borgwardt S., Bourque J., Brandeis D., Breier A., Brodaty H., Brouwer R.M., Buitelaar J.K., Busatto G.F., Buckner R.L., Calhoun V., Canales-Rodriguez E.J., Cannon D.M., Caseras X., Castellanos F.X., Cervenka S., Chaim-Avancini T.M., Ching C.R.K., Chubar V., Clark V.P., Conrod P., Conzelmann A., Crespo-Facorro B., Crivello F., Crone E.A., Dale A.M., Dannlowski U., Davey C., de Geus E.J.C., de Haan L., de Zubicaray G.I., den Braber A., Dickie E.W., Di Giorgio A., Doan N.T., Dorum E.S., Ehrlich S., Erk S., Espeseth T., Fatouros-Bergman H., Fisher S.E., Fouche J.P., Franke B., Frodl T., Fuentes-Claramonte P., Glahn D.C., Gotlib I.H., Grabe H.J., Grimm O., Groenewold N.A., Grotegerd D., Gruber O., Gruner P., Gur R.E., Gur R.C., Hahn T., Harrison B.J., Hartman C.A., Hatton S.N., Heinz A., Heslenfeld D.J., Hibar D.P., Hickie I.B., Ho B.C., Hoekstra P.J., Hohmann S., Holmes A.J., Hoogman M., Hosten N., Howells F.M., Hulshoff Pol H.E., Huyser C., Jahanshad N., James A., Jernigan T.L., Jiang J., Jonsson E.G., Joska J.A., Kahn R., Kalnin A., Kanai R., Klein M., Klyushnik T.P., Koenders L., Koops S., Kramer B., Kuntsi J., Lagopoulos J., Lazaro L., Lebedeva I., Lee W.H., Lesch K.P., Lochner C., Machielsen M.W.J., Maingault S., Martin N.G., Martinez-Zalacain I., Mataix-Cols D., Mazoyer B., McDonald C., McDonald B.C., McIntosh A.M., McMahon K.L., McPhilemy G., Meinert S., Menchon J.M., Medland S.E., Meyer-Lindenberg A., Naaijen J., Najt P., Nakao T., Nordvik J.E., Nyberg L., Oosterlaan J., de la Foz V.O., Paloyelis Y., Pauli P., Pergola G., Pomarol-Clotet E., Portella M.J., Potkin S.G., Radua J., Reif A., Rinker D.A., Roffman J.L., Rosa P.G.P., Sacchet M.D., Sachdev P.S., Salvador R., Sanchez-Juan P., Sarro S., Satterthwaite T.D., Saykin A.J., Serpa M.H., Schmaal L., Schnell K., Schumann G., Sim K., Smoller J.W., Sommer I., Soriano-Mas C., Stein D.J., Strike L.T., Swagerman S.C., Tamnes C.K., Temmingh H.S., Thomopoulos S.I., Tomyshev A.S., Tordesillas-Gutierrez D., Trollor J.N., Turner J.A., Uhlmann A., van den Heuvel O.A., van den Meer D., van der Wee N.J.A., van Haren N.E.M.D., van 't Ent, van Erp T.G.M., Veer I.M., Veltman D.J., Voineskos A., Volzke H., Walter H., Walton E., Wang L., Wang Y., Wassink T.H., Weber B., Wen W., West J.D., Westlye L.T., Whalley H., Wierenga L.M., Wittfeld K., Wolf D.H., Worker A., Wright M.J., Yang K., Yoncheva Y., Zanetti M.V., Ziegler G.C., Karolinska Schizophrenia P., Thompson P.M., Dima D. Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3&#x2013;90 years. Hum. Brain Mapp. 2022;43:431&#x2013;451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8675431</ArticleId><ArticleId IdType="pubmed">33595143</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu T., Kobeleva X., Bronzlik P., N&#xf6;sel P., Dadak M., Lanfermann H., Petri S., Ding X.-Q. Clinically applicable quantitative magnetic resonance morphologic measurements of grey matter changes in the human brain. Brain Sci. 2021;11(1):55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7824828</ArticleId><ArticleId IdType="pubmed">33466559</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon P.H., Cheng B., Salachas F., Pradat P.-F., Bruneteau G., Corcia P., Lacomblez L., Meininger V. Progression in ALS is not linear but is curvilinear. J. Neurol. 2010;257(10):1713&#x2013;1717.</Citation><ArticleIdList><ArticleId IdType="pubmed">20532545</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal N.A., Berry J.D., Windebank A., Staff N.P., Maragakis N.J., Berg L.H., Genge A., Miller R., Baloh R.H., Kern R., Gothelf Y., Lebovits C., Cudkowicz M. Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS. Muscle Nerve. 2020;62(2):156&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7496557</ArticleId><ArticleId IdType="pubmed">31899540</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao Y., Chen R., Ke X., Chu K., Lu Z., Herskovits E.H. Predictive models of autism spectrum disorder based on brain regional cortical thickness. Neuroimage. 2010;50(2):589&#x2013;599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2823830</ArticleId><ArticleId IdType="pubmed">20026220</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin K., Zhang T., Shaw M., Sachdev P., Cherbuin N. Relationship between sulcal characteristics and brain aging. Front. Aging Neurosci. 2018;10:339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6240579</ArticleId><ArticleId IdType="pubmed">30483112</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra S., M&#xfc;ller H.-P., Ishaque A., Zinman L., Korngut L., Genge A., Beaulieu C., Frayne R., Graham S.J., Kassubek J. A prospective harmonized multicenter DTI study of cerebral white matter degeneration in ALS. Neurology. 2020;95(8):e943&#x2013;e952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7668555</ArticleId><ArticleId IdType="pubmed">32646955</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., Burrell J.R., Zoing M.C. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942&#x2013;955.</Citation><ArticleIdList><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Talbot K., McDermott C.J., Hardiman O., Shefner J.M., Al-Chalabi A., Huynh W., Cudkowicz M., Talman P., Van den Berg L.H., Dharmadasa T., Wicks P., Reilly C., Turner M.R. Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nat Rev Neurol. 2021;17(2):104&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7747476</ArticleId><ArticleId IdType="pubmed">33340024</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan J.Y., Meoded A., Danielian L.E., Wu T., Floeter M.K. Structural imaging differences and longitudinal changes in primary lateral sclerosis and amyotrophic lateral sclerosis. Neuroimage Clin. 2012;2:151&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3778247</ArticleId><ArticleId IdType="pubmed">24179768</ArticleId></ArticleIdList></Reference><Reference><Citation>Livshits I., Hussein S., Kennedy C., Weinstock-Guttman B., Hojnacki D., Zivadinov R. Comparison of a 1.5T standard vs. 3T optimized protocols in multiple sclerosis patients. Minerva Med. 2012;103:97&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">22513514</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G., Marin B., Piccininni M., Arcuti S., Chi&#xf2; A., Hardiman O., Rooney J., Zoccolella S., Couratier P., Preux P.-M., Beghi E., Fasano A. Referral bias in ALS epidemiological studies. PLoS ONE. 2018;13(4):e0195821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901916</ArticleId><ArticleId IdType="pubmed">29659621</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E., Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr. Opin. Neurol. 2019;32:771&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Lule D., Burkhardt C., Abdulla S., B&#xf6;hm S., Kollewe K., Uttner I., Abrahams S., Bak T.H., Petri S., Weber M., Ludolph A.C. The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: a cross-sectional comparison of established screening tools in a German-Swiss population. Amyotroph. Lateral Scler. Frontotemporal Degener. 2015;16(1-2):16&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">25292386</ArticleId></ArticleIdList></Reference><Reference><Citation>Machts J., Loewe K., Kaufmann J., Jakubiczka S., Abdulla S., Petri S., Dengler R., Heinze H.-J., Vielhaber S., Schoenfeld M.A., Bede P. Basal ganglia pathology in ALS is associated with neuropsychological deficits. Neurology. 2015;85(15):1301&#x2013;1309.</Citation><ArticleIdList><ArticleId IdType="pubmed">26385880</ArticleId></ArticleIdList></Reference><Reference><Citation>Magen I., Yacovzada N.S., Yanowski E., Coenen-Stass A., Grosskreutz J., Lu C.-H., Greensmith L., Malaspina A., Fratta P., Hornstein E. Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis. Nat. Neurosci. 2021;24(11):1534&#x2013;1541.</Citation><ArticleIdList><ArticleId IdType="pubmed">34711961</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke R.A., Korner S., Filippini N., Douaud G., Knight S., Talbot K., Turner M.R. Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis. Brain. 2014;137:2546&#x2013;2555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4132644</ArticleId><ArticleId IdType="pubmed">24951638</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezzapesa D.M., D&#x2019;Errico E., Tortelli R., Distaso E., Cortese R., Tursi M., Federico F., Zoccolella S., Logroscino G., Dicuonzo F., Simone I.L., Pirko I. Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis. PLoS ONE. 2013;8(11):e80748.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3835750</ArticleId><ArticleId IdType="pubmed">24278317</ArticleId></ArticleIdList></Reference><Reference><Citation>Park M.T., Pipitone J., Baer L.H., Winterburn J.L., Shah Y., Chavez S., Schira M.M., Lobaugh N.J., Lerch J.P., Voineskos A.N., Chakravarty M.M. Derivation of high-resolution MRI atlases of the human cerebellum at 3T and segmentation using multiple automatically generated templates. Neuroimage. 2014;95:217&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pubmed">24657354</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira J.B., Ibarretxe-Bilbao N., Marti M.-J., Compta Y., Junqu&#xe9; C., Bargallo N., Tolosa E. Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness. Hum. Brain Mapp. 2012;33(11):2521&#x2013;2534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6870035</ArticleId><ArticleId IdType="pubmed">21898679</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell T., Gaur N., Steinbach R., Witte O.W., Grosskreutz J. Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data. Health Qual Life Outcomes. 2020;18:117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195704</ArticleId><ArticleId IdType="pubmed">32357946</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C., Kasper E., Machts J., Bittner D., Kaufmann J., Benecke R., Teipel S., Vielhaber S., Prudlo J. Focal thinning of the motor cortex mirrors clinical features of amyotrophic lateral sclerosis and their phenotypes: a neuroimaging study. J. Neurol. 2013;260(11):2856&#x2013;2864.</Citation><ArticleIdList><ArticleId IdType="pubmed">23996101</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C., Kasper E., Machts J., Bittner D., Kaufmann J., Benecke R., Teipel S., Vielhaber S., Prudlo J. Longitudinal course of cortical thickness decline in amyotrophic lateral sclerosis. J. Neurol. 2014;261(10):1871&#x2013;1880.</Citation><ArticleIdList><ArticleId IdType="pubmed">25022938</ArticleId></ArticleIdList></Reference><Reference><Citation>Seiger R., Ganger S., Kranz G.S., Hahn A., Lanzenberger R. Cortical thickness estimations of FreeSurfer and the CAT12 toolbox in patients with alzheimer's disease and healthy controls. J. Neuroimaging. 2018;28(5):515&#x2013;523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6174993</ArticleId><ArticleId IdType="pubmed">29766613</ArticleId></ArticleIdList></Reference><Reference><Citation>Senda J., Atsuta N., Watanabe H., Bagarinao E., Imai K., Yokoi D., Riku Y., Masuda M., Nakamura R., Watanabe H., Ito M., Katsuno M., Naganawa S., Sobue G. Structural MRI correlates of amyotrophic lateral sclerosis progression. J. Neurol. Neurosurg. Psychiatry. 2017;88(11):901&#x2013;907.</Citation><ArticleIdList><ArticleId IdType="pubmed">28501822</ArticleId></ArticleIdList></Reference><Reference><Citation>Sicotte N.L., Voskuhl R.R., Bouvier S., Klutch R., Cohen M.S., Mazziotta J.C. Comparison of multiple sclerosis lesions at 1.5 and 3.0 Tesla. Invest. Radiol. 2003;38:423&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pubmed">12821856</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorenson E.J., Mandrekar J., Crum B., Stevens J.C. Effect of referral bias on assessing survival in ALS. Neurology. 2007;68(8):600&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pubmed">17310031</ArticleId></ArticleIdList></Reference><Reference><Citation>Spalthoff R., Gaser C., Nenadic I. Altered gyrification in schizophrenia and its relation to other morphometric markers. Schizophr. Res. 2018;202:195&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">30049600</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli E.G., Agosta F., Ferraro P.M., Riva N., Lunetta C., Falzone Y.M., Comi G., Falini A., Filippi M. Brain MR imaging in patients with lower motor neuron-predominant disease. Radiology. 2016;280(2):545&#x2013;556.</Citation><ArticleIdList><ArticleId IdType="pubmed">26963576</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli E.G., Riva N., Rancoita P.M.V., Schito P., Doretti A., Poletti B., Di Serio C., Silani V., Filippi M., Agosta F. Structural MRI outcomes and predictors of disease progression in amyotrophic lateral sclerosis. Neuroimage Clin. 2020;27:102315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7327879</ArticleId><ArticleId IdType="pubmed">32593977</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbach R., Gaur N., Stubendorff B., Witte O.W., Grosskreutz J. Developing a neuroimaging biomarker for amyotrophic lateral sclerosis: multi-center data sharing and the road to a &#x201c;global cohort&#x201d;. Front. Neurol. 2018;9:1055.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6288231</ArticleId><ArticleId IdType="pubmed">30564187</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbach R., Batyrbekova M., Gaur N., Voss A., Stubendorff B., Mayer T.E., Gaser C., Witte O.W., Prell T., Grosskreutz J. Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis. Neuroimage Clin. 2020;25:102094.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6940701</ArticleId><ArticleId IdType="pubmed">31896467</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbach R., Gaur N., Roediger A., Mayer T.E., Witte O.W., Prell T., Grosskreutz J. Disease aggressiveness signatures of amyotrophic lateral sclerosis in white matter tracts revealed by the D50 disease progression model. Hum. Brain Mapp. 2021;42:737&#x2013;752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7814763</ArticleId><ArticleId IdType="pubmed">33103324</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbach R., Prell T., Gaur N., Roediger A., Gaser C., Mayer T.E., Witte O.W., Grosskreutz J. Patterns of grey and white matter changes differ between bulbar and limb onset amyotrophic lateral sclerosis. Neuroimage Clin. 2021;30:102674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8099783</ArticleId><ArticleId IdType="pubmed">33901988</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakore N.J., Lapin B.R., Pioro E.P., Pooled Resource Open-Access A.L.S.C.T.C. Trajectories of impairment in amyotrophic lateral sclerosis: Insights from the Pooled Resource Open-Access ALS Clinical Trials cohort. Muscle Nerve. 2018;57:937&#x2013;945.</Citation><ArticleIdList><ArticleId IdType="pubmed">29244213</ArticleId></ArticleIdList></Reference><Reference><Citation>Tullo S., Devenyi G.A., Patel R., Park M.T.M., Collins D.L., Chakravarty M.M. Warping an atlas derived from serial histology to 5 high-resolution MRIs. Sci. Data. 2018;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6007088</ArticleId><ArticleId IdType="pubmed">29917012</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner, M.R., Grosskreutz, J., Kassubek, J., Abrahams, S., Agosta, F., Benatar, M., Filippi, M., Goldstein, L.H., van den Heuvel, M., Kalra, S., Lule, D., Mohammadi, B., first Neuroimaging Symosium in, A.L.S., 2011. Towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurol 10, 400-403.</Citation><ArticleIdList><ArticleId IdType="pubmed">21511189</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Verstraete E. What does imaging reveal about the pathology of amyotrophic lateral sclerosis? Curr. Neurol. Neurosci Rep. 2015;15:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4443002</ArticleId><ArticleId IdType="pubmed">26008817</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Agosta F., Bede P., Govind V., Lul&#xe9; D., Verstraete E. Neuroimaging in amyotrophic lateral sclerosis. Biomark Med. 2012;6(3):319&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pubmed">22731907</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Burgh H.K., Westeneng H.-J., Walhout R., van Veenhuijzen K., Tan H.H.G., Meier J.M., Bakker L.A., Hendrikse J., van Es M.A., Veldink J.H., van den Heuvel M.P., van den Berg L.H. Multimodal longitudinal study of structural brain involvement in amyotrophic lateral sclerosis. Neurology. 2020;94(24):e2592&#x2013;e2604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7455328</ArticleId><ArticleId IdType="pubmed">32414878</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es M.A., Hardiman O., Chio A., Al-Chalabi A., Pasterkamp R.J., Veldink J.H., van den Berg L.H. Amyotrophic lateral sclerosis. Lancet. 2017;390(10107):2084&#x2013;2098.</Citation><ArticleIdList><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstraete E., van den Heuvel M.P., Veldink J.H., Blanken N., Mandl R.C., Hulshoff Pol H.E., van den Berg L.H., Zhan W. Motor network degeneration in amyotrophic lateral sclerosis: a structural and functional connectivity study. PLoS ONE. 2010;5(10):e13664.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2965124</ArticleId><ArticleId IdType="pubmed">21060689</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstraete E., Veldink J.H., Hendrikse J., Schelhaas H.J., van den Heuvel M.P., van den Berg L.H. Structural MRI reveals cortical thinning in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2012;83(4):383&#x2013;388.</Citation><ArticleIdList><ArticleId IdType="pubmed">21965521</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstraete E., Turner M.R., Grosskreutz J., Filippi M., Benatar M. Mind the gap: the mismatch between clinical and imaging metrics in ALS. Amyotroph. Lateral Scler. Frontotemporal Degener. 2015;16(7-8):524&#x2013;529.</Citation><ArticleIdList><ArticleId IdType="pubmed">26402254</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng H.-J., Verstraete E., Walhout R., Schmidt R., Hendrikse J., Veldink J.H., van den Heuvel M.P., van den Berg L.H. Subcortical structures in amyotrophic lateral sclerosis. Neurobiol. Aging. 2015;36(2):1075&#x2013;1082.</Citation><ArticleIdList><ArticleId IdType="pubmed">25281019</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng H.-J., Debray T.P.A., Visser A.E., van Eijk R.P.A., Rooney J.P.K., Calvo A., Martin S., McDermott C.J., Thompson A.G., Pinto S., Kobeleva X., Rosenbohm A., Stubendorff B., Sommer H., Middelkoop B.M., Dekker A.M., van Vugt J.J.F.A., van Rheenen W., Vajda A., Heverin M., Kazoka M., Hollinger H., Gromicho M., K&#xf6;rner S., Ringer T.M., R&#xf6;diger A., Gunkel A., Shaw C.E., Bredenoord A.L., van Es M.A., Corcia P., Couratier P., Weber M., Grosskreutz J., Ludolph A.C., Petri S., de Carvalho M., Van Damme P., Talbot K., Turner M.R., Shaw P.J., Al-Chalabi A., Chi&#xf2; A., Hardiman O., Moons K.G.M., Veldink J.H., van den Berg L.H. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 2018;17(5):423&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">29598923</ArticleId></ArticleIdList></Reference><Reference><Citation>Winterburn J.L., Pruessner J.C., Chavez S., Schira M.M., Lobaugh N.J., Voineskos A.N., Chakravarty M.M. A novel in vivo atlas of human hippocampal subfields using high-resolution 3 T magnetic resonance imaging. Neuroimage. 2013;74:254&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pubmed">23415948</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo C.W., Krishnan A., Wager T.D. Cluster-extent based thresholding in fMRI analyses: pitfalls and recommendations. Neuroimage. 2014;91:412&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4214144</ArticleId><ArticleId IdType="pubmed">24412399</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>